EpiPen
Cases of skin cancer set to reach 263,000 in 2035 according to new report
The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe
Lilly commits additional $4.5bn for US manufacturing sites
The company has also opened its first dedicated genetic medicine facility in Indiana in the US
Potential US-Iran peace deal to redraw market winners and losers
With a 10-day ceasefire between Israel and Lebanon in effect, oil prices are retreating from recent highs
Novo Nordisk agrees to lower certain drug prices in the US
The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid
Lilly announces agreement with US government to lower patient costs
The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels
Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.
In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...
Communicating value to US Payers: Insights for Pharma and Medtech
What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...
What is willingness to pay? – Comparing price testing methodologies
Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to...
Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development
Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...
Ten participating drugmakers invited for further US Medicare drug price negotiations
ASPE revealed that the IRA is expected to save around 857,000 US women $1,000 or more in 2025
Drugmakers submit counteroffers to US Medicare pricing negotiations
New negotiated prices are set to be announced by 1 September 2024 and implemented in 2026
Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics
Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...